These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6299762)

  • 21. Presynaptic alpha-2 adrenoceptor activation and coupling of the receptor-presynaptic effector system in the perfused rat heart: affinity and efficacy of phenethylamines and imidazoline derivatives.
    Fuder H; Braun HJ; Schimkus R
    J Pharmacol Exp Ther; 1986 Apr; 237(1):237-45. PubMed ID: 3007739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of alpha-1 adrenoreceptors of rat aorta by analogs of imidazoline.
    Lamba-Kanwal VK; Hamada A; Adejare A; Clark MT; Miller DD; Patil PN
    J Pharmacol Exp Ther; 1988 Jun; 245(3):793-7. PubMed ID: 2838604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clonidine and related imidazolines are postsynaptic alpha adrenergic antagonists in dispersed rat parotid cells.
    Davis JN; Maury W
    J Pharmacol Exp Ther; 1978 Nov; 207(2):425-30. PubMed ID: 213554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Imidazoline receptors. Historic review and current status of knowledge].
    Moura D
    Acta Med Port; 1993 Dec; 6(12):599-604. PubMed ID: 8165931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Receptor interactions of imidazolines. XI. Alpha-adrenergic and antihypertensive effects of clonidine and its methylene-bridged analog, St 1913.
    Ruffolo RR; Yaden EL; Waddell JE; Ward JS
    Pharmacology; 1982; 25(4):187-201. PubMed ID: 6128747
    [No Abstract]   [Full Text] [Related]  

  • 26. Evidence that the purported dopaminergic agonist (3,4-dihydroxyphenylimino)-2-imidazolidine (DPI) may reduce rat striatal dopamine turnover by an alpha 2-adrenergic mechanism.
    van Oene JC; Houwing HA; Horn AS
    Eur J Pharmacol; 1982 Jun; 81(1):75-87. PubMed ID: 6126370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurochemical and behavioral effects of clonidine and related imidazolines: interaction with alpha-adrenoceptors.
    Skolnick P; Daly JW; Segal DS
    Eur J Pharmacol; 1978 Feb; 47(4):451-5. PubMed ID: 204500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adrenoceptor blocking properties of the stereoisomers of amosulalol (YM-09538) and the corresponding desoxy derivative (YM-11133).
    Honda K; Takenaka T; Miyata-Osawa A; Terai M
    J Pharmacol Exp Ther; 1986 Mar; 236(3):776-83. PubMed ID: 2869143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions of agonists with peripheral alpha-adrenergic receptors.
    Ruffolo RR
    Fed Proc; 1984 Nov; 43(14):2910-6. PubMed ID: 6149156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DPI, a supposed selective agonist of inhibitory dopamine receptors, strongly increases rat diuresis through alpha-adrenergic receptor activation.
    Baggio G; Ferrari F
    Life Sci; 1981 Mar; 28(13):1449-56. PubMed ID: 6113526
    [No Abstract]   [Full Text] [Related]  

  • 31. Conformational requirements of alpha 2-adrenergic receptors.
    Ruffolo RR; Anderson KS; Miller DD
    Mol Pharmacol; 1982 Mar; 21(2):259-61. PubMed ID: 6285164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation of alpha-adrenergic receptors using pharmacological evaluation and molecular modeling of selective adrenergic agents.
    Hancock AA; Kyncl JJ; Martin YC; DeBernardis JF
    J Recept Res; 1988; 8(1-4):23-46. PubMed ID: 2898529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Receptor interactions of imidazolines. II. Affinities and efficacies of hydroxy-substituted tolazoline derivatives in rat aorta.
    Ruffolo RR; Dillard RD; Yaden EL; Waddell JE
    J Pharmacol Exp Ther; 1979 Oct; 211(1):74-9. PubMed ID: 40014
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of fluorine substitution on the agonist specificity of norepinephrine.
    Cantacuzene D; Kirk KL; McCulloh DH; Creveling CR
    Science; 1979 Jun; 204(4398):1217-9. PubMed ID: 221978
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of imidazoline and non-imidazoline α-adrenergic agents on rabbit platelet aggregation.
    Yokota S; Hikasa Y; Mizushima H
    Pharmacology; 2013; 91(3-4):135-44. PubMed ID: 23364471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adrenoceptor-mediated effects of optically active catecholimidazolines in pithed rat.
    Ruffolo RR; Patil PN; Miller DD
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Jul; 323(3):221-7. PubMed ID: 6312335
    [No Abstract]   [Full Text] [Related]  

  • 37. Molecular aspects of the receptor activation by imidazolines: an overview.
    Patil PN; Feller DR; Miller DD
    J Neural Transm Suppl; 1991; 34():187-94. PubMed ID: 1667871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenyliminoimidazolidines. Characterization of a class of potent agonists of octopamine-sensitive adenylate cyclase and their use in understanding the pharmacology of octopamine receptors.
    Nathanson JA
    Mol Pharmacol; 1985 Sep; 28(3):254-68. PubMed ID: 2993848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological classification of adrenergic alpha receptors in the guinea pig.
    Wikberg JE
    Nature; 1978 May; 273(5658):164-6. PubMed ID: 25390
    [No Abstract]   [Full Text] [Related]  

  • 40. Agonistic actions of DPI (2-(3,4-dihydroxyphenylimino)-imidazolidine) on alpha-adrenoceptors and dopamine receptors.
    Woodman OL; Medgett IC; Lang WJ; Rand MJ
    Eur J Pharmacol; 1981 Oct; 75(1):11-9. PubMed ID: 6119208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.